Amniotic Membrane Transplantation
`for Persistent Epithelial Defects
`With Ulceration
`
`SHWU-HUEY LEE, MD, AND SCHEFFER C. G. TSENG, MD, PHD
`
`• PURPOSE: To determine whether preserved hu­
`man amniotic membrane can be used as an alterna­
`tive substrate for treating persistent corneal epi­
`thelial defects with sterile ulceration.
`• METHODS: Amniotic membrane transplantation
`was performed in 11 eyes of 11 consecutive
`patients with corneal ulcers of different causes
`that had persisted for a mean ± SD of 17.5 ± 13.9
`weeks.
`• RESULTS: Ten patients healed in 3.9 ± 2.3
`weeks (P < .01) without recurrence for 9.0 ± 5 .9
`months. One patient failed to heal because of
`preexisting corneal perforation pursuant to severe
`rheumatoid arthritis.
`• CONCLUSION: Amniotic membrane transplan­
`tation may be considered an alternative method for
`treating persistent epithelial defects and sterile
`ulceration that are refractory to conventional
`treatment and before considering treatment by
`conjunctival flaps or tarsorrhaphy.
`
`T HE INITIAL EVENT LEADING TO A CORNEAL EPI-
`
`thelial defect that progresses to ulceration is
`the breakdown of the corneal epithelial sur-
`
`Accepted for publication Oct 17, 1996.
`From the Ocular Surface and Tear Center, Department of Ophthal­
`mology, Bascom Palmer Eye Institute (Drs Tseng and Lee); and Depart­
`ment of Cell Biology and Anatomy (Dr Tseng), University of Miami
`School of Medicine, Miami, Florida. Presented in part at the Second
`Annual Meeting of the Ocular Surface and Tear Workshop, April 1996,
`Miami, Florida. Supported in part by Public Health Service Research
`Grant EY 10900 from Department of Health and Human Services,
`National Eye Institute, National Institutes of Health, Bethesda, Maryland,
`and in part by an unrestricted grant from Research to Prevent Blindness,
`Inc, New York, New York.
`Reprint requests to Scheffer C. G. Tseng, MD, PhD, Bascom Palmer
`Eye Institute, William L. McKnight Vision Research Center, 1638 NW
`10th Ave, Miami, FL 33136; fax: (305) 326-6306; e-mail: stseng®
`mednet.med.miami.edu
`
`face. Surface epithelial breakdown can be caused by
`such exogenous insults as infection, xerosis, trauma,
`or chemicals and can be aggravated by such endoge­
`nous conditions as paralytic or neurotrophic exposure,
`keratomalacia, or recurrent corneal erosions. When
`associated with excessive inflammation or failure of
`normal healing responses, such epithelial breakdown
`may eventually progress to persistent sterile corneal
`ulcers.1'3 Therefore, early diagnosis and institution of
`appropriate medical therapies to correct the underly­
`ing cause, to suppress the untoward inflammation,
`or to augment tissue healing are often curative in
`the management of corneal epithelial defects and
`ulcers.1,2
`However, for reasons that remain unclear, the
`established ulceration can persist and predispose to
`imminent perforation even after the application of
`these therapies. When persistent epithelial defect
`with ulceration develops, we often resort to such
`surgical therapies as tissue adhesive,4,5 conjunctival
`resection,6 lamellar keratoplasty,7 and penetrating
`keratoplasty.2,3,8 However, when there is poor visual
`potential, treatment with conjunctival flaps9,10 or
`tarsorrhaphy11 is contemplated.
`Recently, Kim and Tseng12 reported that amniotic
`membrane transplantation offers a 40% chance of
`restoring corneal clarity and the epithelial phenotype
`in rabbits (n = 13) in which the entire corneal and
`limbal surface had been experimentally destroyed,
`leading to a condition termed limbal stem cell defi­
`ciency. Based on this encouraging finding, we exam­
`ined the question whether the preserved human
`amniotic membrane can also be used as an alternative
`substrate to treat persistent epithelial defects with
`ulceration.
`
`VOL.123, No. 3
`
`© AMERICAN JOURNAL OF OPHTHALMOLOGY 1997;123:303-312
`
`303
`
`MTF Ex. 1040, pg. 1
`
`

`

`Table. Demographic and Clinical Data
`
`Patient No.,
`Age (yrs),
`Sex
`
`Eye
`
`Primary
`Diagnosis
`
`Secondary
`Diagnosis
`
`Previous
`Pertinent
`Treatments
`
`PED
`(wks)
`
`Healed
`(wks)
`
`Treatments
`With
`AMT
`
`Follow-up
`(mos)
`
`Status of
`Amniotic
`Membrane
`
`1, 69, M LE Postinfection
`2, 76, F RE Postinfection
`
`HSK, glaucoma
`Glaucoma
`
`3, 79, F RE Postinfection
`4, 81, M LE Neurotrophic
`
`Aplastic anemia
`HZO, PKP
`
`5, 30, M RE Neurotrophic
`6, 86, F RE Neurotrophic
`7, 73, M RE Neurotrophic,
`exposure,
`exophthalmos
`
`PKP
`Glaucoma
`Graves thyroid
`ophthalmopathy
`
`8, 75, M LE Recurrent
`corneal
`erosion
`9, 79, F RE Cicatricial
`
`PBK, glaucoma
`
`Entropion
`
`10, 72, M LE Cicatricial
`
`Glaucoma
`
`11,49, F RE Corneal
`perforation
`
`RA, SS
`
`Mean 69.9 ±
`± SD 16.3
`
`SCL, patching
`
`Pressure patch, SCL,
`tarsorrhaphy, orbital
`decompression,
`hyperbaric oxygen,
`EGF
`SCL, scraping,
`puncture
`
`PO, eyelid eversion,
`tarsorrhaphy
`
`6
`13
`
`3
`13
`
`32
`12
`52
`
`10
`
`24
`
`12
`
`16
`
`SCL
`SCL
`
`SCL
`
`SCL
`
`SCL, patching
`
`19
`6
`
`13
`3.4
`
`14
`3.7
`2.1
`
`Intact
`Dissolved in
`2 mos
`Intact
`Three layers,
`intact
`Dissolved
`Dissolved
`Two layers,
`intact
`
`SCL
`
`14
`
`Intact
`
`3
`
`8
`
`No
`
`SCL
`
`SCL
`
`—
`
`12.5
`
`Dissolved
`
`2
`
`9*
`
`Two layers
`intact
`Dissolved
`
`17.5 ±
`13.9
`
`3.9 ±
`2.3
`
`9.0 ±
`5.9
`
`*Not counted in the mean follow-up time.
`AMT = amniotic membrane transplantation; cicatricial = cicatricial keratoconjunctivitis without specific diagnosis; EGF = epider­
`mal growth factor; HSK = herpes simplex keratouveitis; HZO = herpes zoster ophthalmicus; PBK = pseudophakic bullous keratoplasty;
`PED = persistent epithelial defect; PKP = penetrating keratoplasty; PO = punctal occlusion; RA = rheumatoid arthritis; SCL = bandage
`soft contact lens; SS = Sjogren syndrome; — = no treatment.
`
`PATIENTS AND METHODS
`
`THE STUDY WAS CONDUCTED UNDER PROTOCOL 93/363,
`approved by the Medical Science Subcommittee for
`the Protection of Human Subjects in Research of the
`University of Miami School of Medicine. From 1994
`to 1996 at the Bascom Palmer Eye Institute, amniotic
`membrane transplantation was performed consecu­
`tively in 11 eyes of 11 patients with corneal epithelial
`defects and ulcers that had persisted for a mean ± SD
`of 17.5 ± 13.9 weeks. These corneal problems had
`diverse causes and had developed after severe micro-
`bial infection (n = 3), neurotrophic keratopathy (n =
`4), recurrent corneal erosion caused by bullous kera­
`topathy (n = 1), cicatricial keratoconjunctivitis (n =
`
`2), or severe keratoconjunctivitis sicca with corneal
`perforation (n = 1) (Table).
`Human amniotic membrane was prepared and
`preserved using our previously described method with
`minor modification.12 The human placenta was ob­
`tained shortly after elective cesarean delivery when
`human immunodeficiency virus, hepatitis virus type
`B, hepatitis virus type C, and syphilis had been
`excluded by serologic tests. Under a lamellar-flow
`hood, the placenta was cleaned of blood clots with
`sterile Earle's balanced saline solution containing 50
`|JLg/ml of penicillin, 50 |xg/ml of streptomycin, 100
`(xg/ml of neomycin, and 2.5 |ig/ml of amphotericin B.
`The amnion was separated from the rest of the
`chorion by blunt dissection through the potential
`
`304
`
`AMERICAN JOURNAL OF OPHTHALMOLOGY
`
`M A R CH
`
`1997
`
`MTF Ex. 1040, pg. 2
`
`

`

`spaces situated between these two tissues and flat­
`tened, with the epithelium/basement membrane sur­
`face up, onto nitrocellulose paper having a pore size of
`0.45 |xm. The paper, with the adherent amniotic
`membrane, was then cut into 3 cm X 4 cm disks and
`stored before transplantation at —80 C in a sterile vial
`containing Dulbecco modified Eagle medium and
`glycerol at the ratio of 1:1 (v/v).
`After retrobulbar anesthetic injection in eyes with
`persistent epithelial defect and ulceration, the base of
`the ulcer was debrided with a microsponge and 0.12
`forceps, and the poorly adherent epithelium adjacent
`to the edge of the ulcer was removed to the area where
`the epithelium became adherent. The amniotic mem­
`brane was then removed from the storage medium,
`peeled from the nitrocellulose filter paper, transferred
`to the recipient eye, and fitted to cover the defect by
`trimming off the excess edges. This fashioned mem­
`brane was then secured to the edge of the defect by
`interrupted 10-0 nylon sutures and, in some cases, by
`a running 10-0 nylon suture. After the knots had
`been buried, the corneal surface became smooth as a
`result of the well-approximated amniotic membrane
`filling in the ulcer bed. Except for deep ulcers, one
`layer of membrane was generally sufficient. A bandage
`contact lens was applied with topical Maxitrol oint­
`ment (neomycin sulfate, polymyxin B sulfate, and
`dexamethasone).
`
`RESULTS
`
`MEAN AGE OF THESE 11 PATIENTS (SIX MEN, FIVE WOMEN)
`was 69.9 ± 16.3 years (Table). Except for the bandage
`contact lens used for 4 months by Patient 2, lenses
`were discontinued in all patients after epithelializa-
`tion. Amniotic membrane transplantation failed in
`Patient 11, who had a preexisting corneal perforation
`caused by severe rheumatoid arthritis; corneal epithe­
`lial defects in the remaining 10 patients healed within
`a mean of 3.9 ± 2.3 weeks (P < .01) (compared with
`17.5 ± 13.9 weeks before the transplantation, exclud­
`ing Patient 11), and none of the 10 experienced any
`recurrence during the 9.0 ±5.9 months of follow-up.
`The transplanted amniotic membrane dissolved in
`five patients (2, 5, 6, 9, and 11), of whom four (except
`Patient 11) remained healed. The dissolution was
`readily identified because the membrane became
`
`more opaque before dissolution. Following are case
`reports for four selected patients.
`
`CASE REPORTS
`
`• CASE l: A 69-year-old man developed an epithelial
`defect and glaucoma following herpes simplex kera-
`touveitis in the left eye 1.5 years before he developed a
`pseudomonas corneal ulcer, which was successfully
`treated with fortified topical antibiotics. However, the
`epithelial defect progressed into stromal ulceration,
`which persisted for 1 month despite various treat­
`ments (Figure 1, a and b). His visual acuity was
`reduced to LE, light perception (Table). After amni­
`otic membrane transplantation, epithelialization en­
`sued and was detected readily 6 days later by fluoresce-
`in staining (Figure 1, c and d). The epithelial defect
`over the amniotic membrane healed within 2 weeks
`(not shown). Interestingly, the transplanted amniotic
`membrane became more transparent 3 months after
`surgery (Figure le). Four months after the amniotic
`membrane transplantation, he underwent successful
`combined penetrating keratoplasty, cataract extrac­
`tion, and lens implantation, resulting in visual acuity
`of LE, 1/200 and a clear graft, which remained stable
`for 19 months thereafter (Figure If).
`
`• CASE 5: A 30-year-old man underwent penetrating
`keratoplasty in his right eye for corneal scarring
`secondary to a neurotrophic corneal ulcer presumably
`caused by long-standing type I diabetes. Immediately
`after, an epithelial defect with ulceration developed
`and persisted for 8 months (Figure 2, a and b) despite
`topical medications, patching, and trials of bandage
`soft contact lens (Table). His visual acuity was RE,
`2/200, corneal sensitivity was decreased, and blink
`rate was reduced. Amniotic membrane transplanta­
`tion resulted in early evidence of epithelialization in 1
`week (Figure 2, c and d), which was complete in 1
`month, during which a soft contact lens was used and
`the
`transplanted amniotic membrane dissolved.
`There was no recurrence for 14 months thereafter;
`the patient's final visual acuity was RE, 2/200 (Figure
`2, e and f).
`
`• CASE 7: A 73-year-old man developed exposure
`keratopathy as a result of exophthalmos and eyelid lag
`
`VOL.123, No. 3
`
`AMNIOTIC MEMBRANE TRANSPLANTATION
`
`305
`
`MTF Ex. 1040, pg. 3
`
`

`

`Figure 1. Patient 1. Persistent epithelial defect with ulceration secondary to postinfectious ulcer and herpes simplex
`keratouveitis. The large area of ulceration was noted (a) without and (b) with fluorescein staining. Compared with the
`postoperative appearance 6 days after surgery (c and d), the amniotic membrane became more transparent 3 months
`later (e). A clear graft was noted after combined penetrating keratoplasty, extracapsular cataract extraction, and
`intraocular lens implantation, which were performed 4 months after amniotic membrane transplantation (f).
`
`306
`
`AMERICAN JOURNAL OF OPHTHALMOLOGY
`
`M A R CH 1997
`
`MTF Ex. 1040, pg. 4
`
`

`

`m
`
`Figure 2. Patient 5. Neurotrophic corneal ulcer following corneal transplantation. The preoperative corneal epithelial
`defect and ulcer by rose bengal staining (a) and fluorescein staining (b). At postoperative week 1 (c), epithelial healing
`had taken place, as shown by fluorescein staining (d). At postoperative month 5 (e and f), the amniotic membrane had
`dissolved, and no recurrence of defect was noted for 11 months thereafter.
`
`VOL.123, N o. 3
`
`AMNIOTIC MEMBRANE TRANSPLANTATION
`
`307
`
`MTF Ex. 1040, pg. 5
`
`

`

`secondary to long-standing Graves thyroid ophthal-
`mopathy. His left eye had been enucleated after severe
`ocular trauma 2 years before our initial examination
`of him. In his right eye he had worn an aphakic
`contact lens for 17 years, and he had developed a
`lens-induced corneal epithelial defect 16 months
`before initial examination but which healed in 1
`month with a bandage soft contact lens. A second
`corneal epithelial defect (4 mm X 6 mm), however,
`had persisted for 1 year despite trials of bandage soft
`contact lens, pressure patching, several attempts of
`partial
`tarsorrhaphy, and one attempt of orbital
`decompression surgery. During this period, he experi­
`enced two episodes of bacterial infection. Because of
`the refractory nature of the ulceration, he had under­
`gone, without success, a course of hyperbaric oxygen
`treatment (Table). Compassionate use of
`topical
`drops containing epidermal growth factor, together
`with advancement of tarsorrhaphy, reduced the de­
`fect to 2 mm X 2.5 mm, but it returned to its original
`size upon discontinuation of the eyedrops and re­
`opening of the eyelid fissure to its original position,
`that
`is, with one-third
`tarsorrhaphy (Figure 3a).
`Because of the patient's single-eye status, amniotic
`membrane transplantation was performed with a
`bandage contact lens and additional patching, which
`resulted in rapid epithelialization as early as 1 week
`after surgery (Figure 3, b and c). The remaining defect
`continued to heal in the following 3 weeks, except for
`an area where the membrane dissolved, leaving a 2
`mm X 2 mm defect (Figure 3d, outlined by arrows). A
`second layer of membrane was placed, which resulted
`in complete healing in 1 week (Figure 3, e and f).
`
`• CASE 8: A 75-year-old man had been treated with
`antiglaucoma eyedrops and laser trabeculoplasties for
`long-standing glaucoma, but complications arose in
`his left eye, with painful bullous keratopathy and
`recurrent corneal erosion for 2.5 months, despite
`trials of bandage contact lens, two scrapings, and
`corneal stromal puncture (Table). His visual potential
`was poor. Intraocular pressure was LE, 30 mm Hg.
`Amniotic membrane transplantation was performed
`limbus to limbus. Within 1 week, epithelialization on
`the epithelium-free membrane from the surrounding
`limbal epithelium began (Figure 4, a and b) and was
`complete 6 weeks after surgery. Interestingly,
`the
`transplanted amniotic membrane became more trans­
`
`parent 2 months postoperatively (Figure 4, c and d).
`The corneal surface remained stable, and the patient
`remained asymptomatic for 14 months thereafter.
`
`DISCUSSION
`
`THREE BASIC SURGICAL STRATEGIES ARE USED TO TREAT
`persistent corneal epithelial defects and ulcers. 2'13,14
`First, mechanical insults to the ocular surface caused
`by misdirected lashes or incomplete closure can be
`eliminated by plastic surgery. Second, the ocular
`surface defense can be augmented by punctal occlu­
`sion to treat keratoconjunctivitis sicca or by tarsorrha­
`phy to prevent exposure and/or neurotrophic keratop­
`athy. Finally, the conjunctival flap can be used as a
`new substrate to replace the damaged corneal stroma.
`Amniotic membranes have been used for other
`indications15: as a graft for burned skin,16 artificial
`vagina, and conjunctival symblepharon 17; as a dress­
`ing for skin wounds18 and for repairing omphalo­
`celes19; or as a substrate to prevent tissue adhesion in
`surgeries of the head, abdomen, 20 and pelvis. Except
`in rare situations, all of these applications use living
`rather than preserved amniotic membranes, and this
`might cause undesirable allograft rejection.
`As indicated here, persistent corneal epithelial
`defects with ulceration can also be effectively man­
`aged by being covered with a layer of preserved
`human amniotic membrane. The amniotic mem­
`brane contains a thick basement membrane and an
`avascular stromal matrix,21'24 and we theorize that
`these features are crucial to successful transplanta­
`tions. The basement membrane facilitates migration
`of epithelial cells,25 reinforces adhesion of basal epi­
`thelial cells,26,27 and promotes epithelial differentia­
`tion.28'31 The basement membrane is also important
`in preventing epithelial apoptosis. 32,33 Collectively,
`these actions explain why the amniotic membrane
`effectively permits rapid epithelialization: here, in a
`mean of 3.9 ± 2.3 weeks after surgery (P < .01) in 10
`of 11 consecutive patients with persistent sterile
`corneal epithelial defects with ulceration. The result­
`ing corneal surface was stable, as shown by the lack of
`recurrence for 9.0 ± 5 .9 months postsurgery and by
`the ability of the treatment to withstand additional
`surgery, for example, penetrating keratoplasty (Figure
`If). Because only the substrate without live cells was
`
`308
`
`AMERICAN JOURNAL OF OPHTHALMOLOGY
`
`M A R CH 1997
`
`MTF Ex. 1040, pg. 6
`
`

`

`Figure 3. Patient 7. Persistent epithelial defect with ulceration secondary to a neurotrophic corneal ulcer and
`penetrating keratopathy caused by Graves thyroid ophthalmopathy. The large area of ulceration was noted in the central
`cornea (a). At postoperative week 1, epithelial healing had taken place (b), as shown by fluorescein staining (c). The
`remaining defect decreased to a smaller size, and the membrane had dissolved by week 4 after surgery (d, outlined by
`arrows). After a second membrane was applied, this defect was completely healed in 1 week (e and f).
`
`VOL.123, No. 3
`
`AMNIOTIC MEMBRANE TRANSPLANTATION
`
`309
`
`MTF Ex. 1040, pg. 7
`
`

`

`Figure 4. Patient 8. Recurrent corneal erosion secondary to glaucoma-induced bullous keratopathy. Amniotic
`membrane transplantation was performed limbus to limbus. Compared with the postoperative appearance at 1 week,
`which showed early epithelialization on the epithelium-free membrane from the surrounding limbal epithelium (a and
`b), the amniotic membrane became more transparent 2 months later (c and d).
`
`transplanted, no adverse effect, such as allograft
`rejection, was noted in any patient.
`We are intrigued that two patients (1 and 8)
`showed gradual transparency
`in the
`transplanted
`amniotic membrane several months after transplanta­
`tion (Figures 1 and 4). A similar finding was also
`noted in experimental rabbit corneas 12 and recently in
`corneal surface reconstruction together with limbal
`allografts in patients with advanced ocular cicatricial
`pemphigoid and Stevens-Johnson syndrome. 34 This
`finding is important and suggests that this procedure
`can be used to restore vision. Studies are needed to
`explore the question whether reorganization of the
`amniotic membrane stroma during wound healing is
`unique and able to reduce commonly noted fibrotic
`
`responses. We were equally intrigued that four pa­
`tients (2, 5, 6, and 9) showed epithelialization despite
`the fact that the transplanted membrane had dis­
`solved (Figure 2e). The dissolution came after the
`opaque appearance of the membrane and was identi­
`fied in patients 2, 5, 6, 9, and 11. Except for Patient
`11, epithelialization lasted in all other patients. We
`have no explanation for this at present.
`Studies are also needed to investigate whether the
`amniotic membrane might contain a growth factor or
`growth factors, liberated from the dissolved mem­
`brane, that stimulate wound healing. Because of the
`failure by topical epidermal growth factor to heal the
`recurrent corneal epithelial defect in Patient 7, we
`wonder whether the amniotic membrane contains
`
`310
`
`AMERICAN JOURNAL OF OPHTHALMOLOGY
`
`M A R CH 1997
`
`MTF Ex. 1040, pg. 8
`
`

`

`growth factors other than epidermal growth factor, or
`alternatively whether the effect of epidermal growth
`factor needs to be augmented with additional matrix
`components. The use of more than one layer of
`amniotic membrane was also effective in covering
`smoothing ulcers of substantial stromal depth (Pa­
`tients 4, 10, and 11). However, this technique might
`be ineffective for treating those with frank corneal
`perforation, as shown by Patient 11.
`In conclusion, amniotic membrane transplantation
`may be considered an alternative substrate for treating
`persistent corneal epithelial defects with sterile ulcer-
`ation that are refractory to conventional medical
`treatment. Based on this and other reports1234 and the
`protocol described herein, it is feasible to obtain
`preserved human amniotic membrane. This new
`procedure can be considered before conjunctival flaps
`or tarsorrhaphy, as shown in the majority of our
`patients, which is especially meaningful in that this
`approach can achieve a better cosmetic appearance
`and potential visual acuity. It can also be considered
`an option even after failed partial tarsorrhaphy, as
`shown by our Patients 7 and 9. We recognize that our
`series is relatively small and that a more extensive
`study is necessary to delineate the influences of
`causation and of spontaneous amniotic tissue dissolu­
`tion, and the effect of postsurgical mediations. Also,
`further investigations and trials may suggest other
`potential uses for human amniotic membrane trans­
`plantation.
`
`ACKNOWLEDGMENTS
`The authors wish to express their deep gratitude to Dr
`Juan Batle of Santo Domingo for introducing us, at
`the Annual Meeting for Residents and Alumni of the
`Bascom Palmer Eye Institute in 1992, to the use of
`amniotic membranes, and to Dr Gene Burkett for
`obtaining donor placentas.
`
`REFERENCES
`
`Kenyon KR. Inflammatory mechanisms in corneal ulcera-
`tion. Tr Am Ophth Soc 1985;83:610-663.
`Donzis PB, Mondino BJ. Management of noninfectious
`corneal ulcers. Surv Ophthalmol 1987;32:94-110.
`Portnoy SL, Insler MS, Kaufman HE. Surgical management
`of corneal ulceration and perforation. Surv Ophthalmol
`1989;34:47-58.
`
`4. Fogle JA, Kenyon KR, Foster CS. Tissue adhesive arrests
`stromal melting in the human cornea. Am J Ophthalmol
`1980;89:795-802.
`5. Golubovic S, Parunovic A. Cyanoacrylate glue in the treat­
`ment of corneal ulcerations. Fortschr Ophthalmol 1990;
`87:378-381.
`6. Feder RS, Krachmer JH. Conjunctival resection for the
`treatment of the rheumatoid corneal ulceration. Ophthal­
`mology 1984;91:111-115.
`7. Bessant DAR, Dart JKG. Lamellar keratoplasty in the
`management of inflammatory corneal ulceration and perfora­
`tion. Eye 1994;8:22-28.
`8. Dixon WS. Treatment of corneal perforations and ulcers
`with primary keratoplasty. In: Draeger J, Winter R, editors.
`New microsurgical concepts. Basel: Karger, 1989:176-180.
`9. Gundersen T. Conjunctival flaps in the treatment of corneal
`disease with reference to a new technique of application.
`Arch Ophthalmol 1958;60:880-888.
`10. Insler MS, Pechous B. Conjunctival flaps revisited. Ophthal­
`mic Surg 1987;18:455-458.
`11. Welch C, Baum J. Tarsorrhaphy for corneal disease in
`patients with
`rheumatoid arthritis. Ophthalmic Surg
`1988;19:31-32.
`12. Kim JC, Tseng SCG. Transplantation of preserved human
`amniotic membrane for surface reconstruction in severely
`damaged rabbit corneas. Cornea 1995;14:473-484.
`13. Kenyon KR, Roberts CW. Noninfected corneal ulceration.
`Int Ophthalmol Clin 1984;24:179-197.
`14- Wagoner MD, Kenyon KR, Foster CS. Management strate­
`gies in peripheral ulcerative keratitis. Int Ophthalmol Clin
`1986;26:147-157.
`15. Trelford JD, Trelford-Sauder M. The amnion in surgery, past
`and present. Am J Obstet Gynecol 1979;134:833-845.
`16. Stern M. The grafting of preserved amniotic membrane to
`burned and ulcerated surfaces, substituting skin grafts. J Am
`Med Assoc 1913;60:973-974.
`17. de Rotth A. Plastic repair of conjunctival defects with fetal
`membrane. Arch Ophthalmol 1940;23:522-525.
`18. Sabella N. Use of the fetal membranes in skin grafting. Med
`Rec N Y 1913;83:478-480.
`19. Tokomori K, Ohkura M, Kitano Y, Hori T, Nakajo T.
`Advantages and pitfalls of amnion inversion repair for the
`treatment of large unruptured omphalocele: results of 22
`cases. J Pediatr Surg 1992;27:882-884.
`20. Badawy SZA, Baggish MS, ElBakry MM, Baltoyannis P.
`Evaluation of tissue healing and adhesion formation after an
`intraabdominal amniotic membrane graft in the rat. ]
`Reproductive Med 1989;34:198-202.
`21. Liotta LA, Lee CW, Morakis DJ. New method for preparing
`large surfaces of intact human basement membrane for tumor
`invasion studies. Cancer Lett 1980;11:141-152.
`22. Russo RG, Thorgeirsson U, Liotta LA. In vitro quantitative
`assay of invasion using human amnion. In: Liotta LA, Hart
`IR, editors. Invasion and metastasis. Dordred: Nijhoff,
`1982:173-187.
`23. Modesti A, Kalebic T, Scarpa S, et al. Type V collagen in
`human amnion is a 12-nm fibrillar component of the
`pericellular interstitium. Eur J Cell Biol 1984;35:246-255.
`24. Campbell S, Allen TD, Moser BB, Aplin JD. The translami-
`nal fibrils of the human amnion basement membrane. J Cell
`Sci 1989;94:307-318.
`25. Terranova VP, Lyall RM. Chemotaxis of human gingival
`epithelial cells to laminin: a mechanism for epithelial cell
`apical migration. J Periodontol 1986;57:311-317.
`
`VOL.123, No. 3
`
`AMNIOTIC MEMBRANE TRANSPLANTATION
`
`311
`
`MTF Ex. 1040, pg. 9
`
`

`

`27
`
`28,
`
`26. Khodadoust AA, Silverstein AM, Kenyon KR, Dowling JE.
`Adhesion of regenerating corneal epithelium: the role of
`basement membrane. Am J Ophthalmol 1968;65:339-348.
`Sonnenberg A, Calafat J, Janssen H, et al. Integrin a6/b4
`complex is located in hemidesmosomes, suggesting a major
`role in epidermal cell-basement membrane adhesion. J Cell
`Biol 1991;113:907-917.
`Guo M, Grinnell F. Basement membrane and human
`epidermal differentiation
`in vitro. J Invest Dermatol
`1989;93:372-378.
`29. Streuli CH, Bailey N, Bissell MJ. Control of mammary
`epithelial differentiation: basement membrane induces tissue-
`specific gene expression in the absence of cell-cell interaction
`and morphological polarity. J Cell Biol 1991;115:1383-1395.
`Kurpakus MA, Stock EL, Jones JCR. The role of the
`basement membrane in differential expression of keratin
`proteins in epithelial cells. Dev Biol 1992;150:243-255.
`
`30.
`
`31. Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ. Func­
`tional differentiation and alveolar morphogenesis of primary
`mammary cultures on reconstituted basement membrane.
`Development 1989;105:223-235.
`32. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of
`ICE and apoptosis in mammary epithelial cells by extracellu­
`lar matrix. Science 1995;267:891-893.
`33. Boudreau N, Werb Z, Bissell MJ. Suppression of apoptosis by
`basement membrane requires three-dimensional tissue orga­
`nization and withdrawal from the cell cycle. Proc Natl Acad
`Sci U S A 1996;93:3500-3513.
`34. Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruc­
`tion of the ocular surface in advanced ocular cicatricial
`pemphigoid and Stevens-Johnson syndrome. Am J Ophthal­
`mol 1996;122:38-52.
`
`Authors Interactive™
`Comments and questions of 100 words or less regarding this article may be
`addressed to authors via THE JOURNAL'S Web Site on the Internet. Selected
`questions and comments along with the authors' statements and responses will
`be posted on the Authors Interactive™ Bulletin Board, a feature of THE
`JOURNAL'S home page. Readers may access THE JOURNAL'S home page and the
`Authors Interactive™ Bulletin Board at http://www.ajo.com/
`
`312
`
`AMERICAN JOURNAL OF OPHTHALMOLOGY
`
`M A R CH 1997
`
`MTF Ex. 1040, pg. 10
`
`

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket